NovoCure Ltd. (NVCR)
12.06
+0.05
(+0.42%)
USD |
NASDAQ |
Mar 13, 16:00
12.07
+0.01
(+0.08%)
After-Hours: 20:00
NovoCure Shareholders Equity (Quarterly) : 340.47M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| LivaNova Plc | 1.200B |
| AtriCure, Inc. | 491.94M |
| Abbott Laboratories | 52.13B |
| Accuray, Inc. | 53.42M |
| Plus Therapeutics, Inc. | 3.996M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 804.33M |
| Total Liabilities (Quarterly) | 463.86M |
| Debt to Equity Ratio | 0.7295 |
| Current Ratio | 2.897 |
| Net Debt Paydown Yield | 5.88% |